4.6 Article

Percutaneous coronary intervention versus coronary artery surgery for left main disease according to lesion site: A meta-analysis

期刊

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.jtcvs.2021.08.040

关键词

coronary artery disease; unprotected left main; coronary artery bypass graft; percutaneous coronary intervention

向作者/读者索取更多资源

This study compared the outcomes of percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) for different lesion sites (ostial/shaft vs distal) in patients with unprotected left main coronary artery (ULMCA) disease. It found that for patients with distal ULMCA disease, CABG is associated with lower incidence of major adverse cardiovascular events (MACE) and revascularization compared with PCI.
Background: Comparative data after percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) for unprotected left main coronary artery (ULMCA) disease according to lesion site (ostial/shaft vs distal) are scant. The aim of this meta-analysis was to investigate outcomes after PCI or CABG for ULMCA dis-ease according to lesion site. Methods: Randomized controlled trials (RCTs) and adjusted observational studies that compared PCI versus CABG in patients with ULMCA disease and reported out-comes according to lesion site were systematically identified. Major adverse cardio-vascular events (MACE; a composite of all-cause death, myocardial infarction, stroke, and repeat revascularization) and all-cause death were the co-primary end points. Individual components of MACE were secondary end points. Sensitivity analysis including RCTs only were performed for each outcome. Results: Nine studies (3 RCTs, 6 adjusted observational), encompassing 6296 patients (2274 and 4022 treated for ostial/shaft or distal ULMCA, respectively) were included. At the 5-year follow-up, there were no significant differences between CABG and PCI for MACE, death, or any other secondary outcome for ostial/shaft ULMCA lesions (MACE: hazard ratio [HR], 1.0 [95% confidence interval (CI), 0.79-1.27]; death: HR, 1.10 [95% CI, 0.84-1.46]). For distal ULMCA, PCI was associated with an increased risk of MACE (HR, 1.32; 95% CI, 1.10-1.58), death (HR, 1.56; 95% CI, 1.19-2.04), and revascularization (HR, 2.07; 95% CI, 1.5-2.84). The benefit of CABG for MACE and revascularization was confirmed in the analysis limited to RCTs, whereas the benefit for mortality was not. Conclusions: Among patients with distal ULMCA disease, CABG is associated with lower incidence of MACE and revascularization compared with PCI, whereas no dif-ferences in outcomes were observed for ostial/shaft ULMCA disease. (J Thorac Car-diovasc Surg 2023;166:120-32)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据